ALLOKIN-ALPHA HOME-MADE ANTIVIRUS NEW-GENERATION DRUG FOR HERPES AND PAPILLOMA VIRAL INFECTION (HPV) TREATMENT FAREWELL TO VIRUS! RUEnglishUA
INSTRUCTION FOR USE ¬идео о проблеме впч PATIENT FEEDBACK
SECTION FOR SPECIALISTS

Modern ways of Genital Herpes treatment

All the information contained on this informational resource is intended exclusively for practitioners and cannot be used by the site visitors for self-diagnosing and prescribing treatment without a previous consultation with the doctor.

Currently, a large quantity of drugs for the treatment of herpetic infection have been developed and applied, a common disadvantage of which is the inability to conduce to clinical cure. The effect of antiviral therapy has usually a short duration.

The main part of antiherpetic drugs is more active during the acute period of recurrent Genital Herpes, because they mainly affect the replication process of the virus and have a small effect on a remission duration. Often the recurrences are occurred again with the same frequency at drug withdrawal. The resistance can be developed to some antiviral drugs. Currently, only 27% of patients diagnosed with Genital Herpes get an antiviral therapy. According to some authors, about 95% of patients with clinical manifestations of Genital Herpes do not get any treatment.

For herpetic infection treatment the following groups of medicines are applied:

  • drugs which suppress the virus replication (Acyclovir and its analogues, Glycyrrhizic acid, etc.);
  • interferons (IFN-2α, IFN-2, IFN, etc.);
  • interferon inducers (Cycloferon, Neovir, Tilorona, etc.);
  • immunomodulators based on the results of immunological examination (Glutamyl-tryptophan, Polyoxidonium, Timalin, Derinat, etc.);
  • drugs for topical application (ointments, containing Acyclovir, Foscavir; Glycyrrhizic acid, Bonafton, etc.);
  • antioxidants, multivitamins, enterosorbents.

Grugs for therapy and preventive treatment of herpesvirus infections
(V. A. Isakov and others, 2006)

I. DRUGS

A. The analogues of nucleoside, pyrophosphates other drugs

B. Drugs "prohibiting off" the cytokines

C. Inhibitors with different mechanism of action

Acyclovir
(Zovirax, Virolex)
Valacyclovir (Valtrex)
Famciclovir (Penciclovir)
Ganciclovir,Valganciclovir*
Vidarabine
Cytarabine
Fomivirsen*
Foscarnet
Ribavirin
Idoxuridine
Triptorelin* Trifuralin*
Cidofovir*
Lobucavir*
Sorivudin*
Brivudin*
Isoprinosine

Allokin-alpha* (the active ingredient is Alloferon)

Riodical
Florenal
Tebrofen
Flakozid, Helepin
Tromantadine
Polirem
Pandavas (Bulgaria)
Epigen (Spain)

II. DRUGS FOR IMMUNOGENETICALLY AND INTERFEROMETRICALLY THERAPY

A. Specific gamma- and immunoglobulins

B. Interferons and their inducers

 

Human immunoglobulin
Cytotect (Germany)
Intraglobin (Germany)
Pentaglobin (Germany)
Vesicbulin (Bulgaria)
Gabriglobin (Russia)

Human leukocyte interferon
Amiksin, Likopid, Viferon
Altevir, Leukinferon
Ridostin, Kamedon, Neovir
Cycloferon, Reaferon
Reaferon-ES-Lipint
Lifeferon
Realderon, Roferon-A (Switzerland),
Polyoxidonium, Vitamedin-M
Wellferon (UK)
Kagocel*

 
III. HERPES VACCINES

A. Live

B. Inactivated

C. Recombinant

 

Vitaherpavac

 

Note:* are new imported and national antiviral drugs

The use of chemotherapeutic drugs, possessing antiherpetic activity, showed that jugulating quickly and effectively the acute symptoms of HI, they do not prevent the recurrence of HI and in some cases even do not reduce their frequency, because they obrigate only the active replication of herpes viruses. So one-time (a course) use of drugs of this group does not prevent the development of the recurrent disease, the infection with a related or new type of herpesvirus, does not affect the immune parameters (V. A. Isakov etc., 1993; L. N. Khakhalin, 1997).

During last years, there have been reports indicating the possibility of forming resistant strains of HSV with using AC. And resistant to AC strains of the herpes virus are mostly often allocated in patients with herpetic pneumonia, encephalitis, skin-mucous form of the HI on the background of evident immunodeficiency.

Certain difficulties are associated with the treatment of patients with frequently Recurrent Genital Herpes (RGH), due to the variety of HV and their pantropical base, the complexity of the developing mechanisms and, course of, the disease, development of resistant to the basic drugs of herpes viruses strains. Therefore, the introduction of a new drug (Allokin-alpha), having a stimulating effect on interferon status and T - cell immunity can be an important link in enhancing the effectiveness of herpes therapy. (F. I. Ershov etc., 2003; V. A. Isakov and others, 2006).

Read more:

Ask your gynecologist if he (she) has an experience in treatment of human papillomavirus infection to the complete removal of human papilloma virus from the body?

Homepage   |   Feedback   |   Site Map   |   Job Vacancies   |   Contacts
© 2004—2017 Brand-Pharm Ltd. All information contained on this website is intended only for medical specialists and cannot be used by visitors for self-diagnosis and treatment. Consult your physician, do not start self-medication!
The website creation and promotion: Alisa Design
яндекс.ћетрика